Pfizer: Get Latest News, Photos and Videos along with latest updates on Pfizer | Hindustan Times

pfizer news


Latest from pfizer

Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial

SHIONOGI-CORONAVIRUS-PILL:Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial

Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial
Published on May 13, 2024 12:58 PM IST
Reuters |

After Boeing deaths, Pfizer ‘whistleblower’ puts out ‘I am not suicidal’ video

Former Pfizer employee Melissa McAtee had raised concerns about mRNA vaccines and potential harm, despite backlash.

Former Pfizer employee Melissa McAtee had raised concerns about mRNA vaccines and potential harm, despite backlash.
Published on May 09, 2024 06:32 PM IST

Pfizer agrees to settle over 10,000 Zantac cancer lawsuits in US

Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug.

Pfizer shares were up 1.5% to $28.19 at 11:55 a.m. in New York.(REUTERS)
Published on May 09, 2024 05:56 PM IST
Bloomberg |

Pfizer reports patient death in Duchenne gene therapy study

PFIZER-DUCHENNE/ (UPDATE 1):UPDATE 1-Pfizer reports patient death in Duchenne gene therapy study

HT Image
Published on May 08, 2024 03:59 AM IST
Reuters |

Pfizer lifts profit view on cost cuts, smaller drop in demand for COVID products

PFIZER-RESULTS/ (UPDATE 2, PIX):UPDATE 2-Pfizer lifts profit view on cost cuts, smaller drop in demand for COVID products

Pfizer lifts profit view on cost cuts, smaller drop in demand for COVID products
Published on May 01, 2024 05:03 PM IST
Reuters |

Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%. Here's why

Pfizer, which currently holds a 32% stake in Haleon, said last May it planned to cut its ownership in a "slow and methodical" manner within months.

The Pfizer logo is seen at their UK commercial headquarters in Walton Oaks, Britain. (Reuters)
Published on Mar 18, 2024 12:53 PM IST
Reuters |

A new year wish for good health

Major achievements in medical science in 2023 include mRNA technology for vaccines, CRISPR gene editing, 3D printing of human organs, and new drugs for weight loss and Alzheimer's. Utilization of continuous personal monitoring systems and artificial intelligence in healthcare also made significant progress. However, it is important to address poverty, nutrition, and access to healthcare to improve overall health.

HT Image
Updated on Dec 31, 2023 11:13 PM IST

Pharmaceutical firms Pfizer, BioNTech sue Poland and Hungary over Covid debts

EU member countries ordered vaccines for their population through joint purchase scheme, and so companies are bringing their case before the courts in Belgium.

Pfizer confirmed the cases were under way but would not confirm the sums demanded. (Reuters)
Published on Dec 19, 2023 07:52 PM IST

Pfizer's updated Covid vaccine effective against 'Eris' variant in mice study

EG.5, nicknamed by some as "Eris", is similar to the XBB.1.5 subvariant and a sub-lineage of the still-dominant Omicron variant.

The World Health Organization classified EG.5 as a
Published on Aug 18, 2023 12:50 AM IST
Reuters |

Video: Tornado rips through Pfizer manufacturing plant amid drug shortage in US

The disaster struck as the US was facing a nine-year-high of drug shortages — 309 medicines are in short supply.

Debris is scattered around the Pfizer facility on Wednesday in Rocky Mount, N.C., after damage from severe weather. (AP)
Updated on Jul 22, 2023 06:55 AM IST

US drug regulator approves world's first RSV vaccine

Respiratory Syncytial Virus vaccine: RSV normally causes mild, cold-like symptoms, but can be serious for people with weak immune systems.

It marks the first such approval globally, with similar vaccines from other makers including Pfizer expected to follow soon.(Representative image)
Published on May 04, 2023 01:26 AM IST

High air pollution hits Covid vaccine response: Study

The research team measured three kinds of antibodies (IgM, IgG and IgA) to five viral antigens (three of them on the spike protein contained in the vaccine).

A woman gets a booster dose of the Covid-19 vaccine in Srinagar.(PTI)
Updated on Apr 07, 2023 06:06 AM IST
By, New Delhi

Jairam Ramesh dismisses Union minster's 'pushing for foreign vaccine' claims

Congress' Jairam Ramesh dismissed claims made in a Twitter post shared by the Union minister- Rajeev Chandrasekhar over the grand old party pushing for Pfizer vaccine at a time when the pharmaceutical company was “bullying” the Centre for its acceptance.

Congress leader Jairam Ramesh said that the Union minister's post “undermines the most basic principles of democracy and fairness”.(PTI)
Updated on Jan 23, 2023 06:57 AM IST
BySnehashish Roy, New Delhi

‘Will Twitter have guts?’: Jairam amps up attack on minister over Pfizer vaccine

Union minister Rajeev Chandrasekhar shared a video on Twitter on Friday about Pfizer CEO Albert Bourla's encounter with a journalist at Davos 2023, and blamed Congress leaders Jairam Ramesh, Rahul Gandhi and P Chidambaram for pushing the case of foreign Covid-19 vaccines in India.

Congress leader Jairam Ramesh (PTI) and Union minister for state for information and technology Rajeev Chandrasekhar.
Updated on Jan 21, 2023 01:24 PM IST
By, New Delhi

Davos 2023: Pfizer CEO evades questions on Covid vaccine efficacy. Watch video

The Pfizer chief time and again ducked the questions, only to say "Thank you very much" and "Have a nice day".

A Rebel News journalist was seen asking a lot of uncomfortable questions to the Pfizer CEO (File)
Published on Jan 20, 2023 02:13 PM IST
ANI | | Posted by Ritu Maria Johny

Pfizer's Paxlovid antiviral can lower post-Covid symptoms by 26%: Study

The research, based on an analysis of electronic health records in databases maintained by the Department of Veterans Affairs, is the first study to look at Paxlovid’s longer-term effects, said Eric Topol, founder of the Scripps Research Translational Institute in La Jolla, California.

Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022. A morning and an evening does consists of one white 100-milligram tablet of Ritonavir and two pink 150-milligram tablets of PF-07321332. REUTERS/Wolfgang Rattay/Illustration(REUTERS)
Published on Nov 07, 2022 01:20 PM IST
Bloomberg |

Pfizer probed in Italy for allegedly hiding $1.2 billion profit

Pfizer’s Italian unit began operating almost 70 years ago and employs about 2,000 workers, according to its website.

Pfizer shares dipped briefly before regaining ground to rise 1.3% as of 3:51 p.m. Wednesday in New York.
Published on Oct 27, 2022 02:33 AM IST
Bloomberg |

Pfizer seeks approval of updated COVID vaccine booster against new variants

Vaccines targeting the coronavirus strain that spread in early 2020 and their effectiveness against infection has dropped markedly as new mutants came along, particularly the super-contagious omicron family.

A health worker administers a dose of a Pfizer COVID-19 vaccine at a vaccination clinic. (AP)
Published on Aug 23, 2022 03:35 PM IST
AP | | Posted by Yagya Sharma

Pfizer files application for booster against latest variants

In a statement, the companies said they had “rapidly scaled production” for the new booster and would be able to ship doses of the new vaccine “immediately” upon emergency authorization.

Pfizer files application for booster against latest variants (AP)
Published on Aug 22, 2022 11:08 PM IST
Bloomberg |

CDC advisers urge Pfizer booster for children ages 5 to 11

If the Centers for Disease Control and Prevention agrees, as expected, it would open a third Covid-19 shot to healthy elementary-age kids — just like what is already recommended for everybody 12 and older.

Earlier this week, the Food and Drug Administration authorized Pfizer's kid-sized booster, to be offered at least five months after the youngsters' last shot.(AP Photo/LM Otero, File)(AP)
Published on May 20, 2022 03:47 AM IST
AP |

US authorises Covid booster shots for children aged 5 to 11

Children will become eligible for the booster at least five months after completing their initial vaccine doses. The dosage is 10 micrograms for both the initial shots and the booster, compared to 30 for those 12 and older.

Children aged 5-11 have been eligible to receive the initial two doses of Pfizer's vaccine since November 2021, but less than 30 per cent of them have so far. (REUTERS/Matt Mills McKnight/File Photo)
Published on May 17, 2022 11:25 PM IST

Pfizer’s Covid drug fails test for preventing infections

The drug, Paxlovid, failed to meet its primary goal of significantly reducing the risk of Covid-19 infection in adults exposed to the virus through a household contact, Pfizer said in a statement Friday.

FILE PHOTO: Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in a box,(REUTERS)
Published on Apr 30, 2022 05:44 AM IST
Bloomberg |

Pfizer’s third Covid shot boosts antibodies in kids 5 to 11

The companies plan to file for emergency-use authorization in the US in the coming days based on the results, according to a statement Thursday. They will also submit the data to other regulators around the world.

Representaioanl image.(HT_PRINT)
Published on Apr 14, 2022 07:59 PM IST
Bloomberg |

Made in India Covid vaccines better than Pfizer, Moderna: SII's Adar Poonawalla

Speaking to ANI, Poonawalla said, "The Covid-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna."

On being asked about the export of the Covishield Covid-19 vaccine, Adar Poonawalla
Published on Apr 13, 2022 04:22 PM IST

Pfizer made 6 million courses of its Covid pill, shipped to over 26 countries

Pfizer spokesperson Sharon Castillo said in an email that the company has shipped the pills to over 26 countries so far.

Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy(Reuters)
Published on Apr 05, 2022 06:57 AM IST
Reuters |

FDA okays 2nd booster of Pfizer, Moderna

For most people, the second booster will be a fourth shot, while it will be the third for those who got initial single-shot immunisations from Johnson & Johnson.

FILE PHOTO: A man receives a booster dose of Pfizer's coronavirus disease.(REUTERS)
Updated on Mar 30, 2022 07:32 AM IST
Agencies | , London

Pfizer vaccine less effective against Covid-19 in kids aged 5-11: Study

The effectiveness of the Pfizer Covid-19 vaccine for children waned quickly during the Omicron surge in the US, especially among those aged 5 to 11 years: Study

How effective is Pfizer vaccine against COVID cases and hospitalisations? A study answers(REUTERS Representative)
Published on Mar 01, 2022 07:06 PM IST
PTI | | Posted by Parmita Uniyal

Pfizer, Moderna booster efficacy wanes significantly by fourth month: Study

It is now well documented that vaccine efficacy goes down after two doses, but relatively little has been published on the duration of protection after a booster.

The WHO earlie that it recommends booster doses of Pfizer-BioNTech vaccine.
Published on Feb 12, 2022 08:35 AM IST

Pfizer's Covid product sales to top $50 bln this year, investors want more

Pfizer currently expects $22 billion in 2022 sales of the treatment, compared with Wall Street estimates of $22.88 billion.

Pfizer expects its 2022 sales of its Covid-19 vaccine and antiviral pill to top $54 billion.(REUTERS)
Published on Feb 09, 2022 03:16 PM IST
Reuters |

Pfizer-BioNTech seek US approval of Covid-19 vaccine for kids under 5

If the Food and Drug Administration (FDA) authorizes the two-shot regimen, it will become the first Covid vaccine available to this age group in the United States.

Pfizer Covid-19 vaccine (Representative Image / AFP)
Published on Feb 02, 2022 06:29 AM IST
  • 1
  • 2
  • ...
Story Saved
Live Score
Saved Articles
My Reads
Sign out
New Delhi 0C
Monday, May 27, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On